The purpose of this study is to determine if treatment with a single dose of RE104 for Injection reduces depressive symptoms or depressive symptoms mixed with anxiety symptoms in participants with Adjustment Disorder due to cancer or other illnesses such as Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), Parkinson's Disease (PD) or Idiopathic Pulmonary Fibrosis (IPF) as compared to active-placebo.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
100
Single, subcutaneous dose of RE104 for Injection
UAB, Psychiatry and Behavioral Neurology
RE104 30 mg versus RE104 1.5 mg change from baseline in MADRS total score
Montgomery-Åsberg Depression Rating Scale (MADRS) is a 10-item clinician rated scale measuring depression severity. The total score ranges from 0-60 with higher scores representing greater severity of depression.
Time frame: Day 7
RE104 30 mg versus RE104 1.5 mg changes in total score from baseline in Hamilton Anxiety Rating Scale (HAM-A)
The Hamilton Rating Scale for Anxiety (HAM-A) is a 14-item scale that is used to rate the severity of symptoms of anxiety. The total score ranges from 0-56 with higher scores representing greater severity of anxiety.
Time frame: Day 7
RE104 30 mg versus RE104 1.5 mg incidence of treatment-emergent adverse events (TEAEs) by frequency, severity and seriousness.
A treatment-emergent adverse event (TEAE) is defined as any unfavorable and unintended sign, symptom or disease temporally associated with the use of a study drug.
Time frame: From dosing through study completion (post-dose follow-up is for 42 days)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Birmingham, Alabama, United States
University of Arizona
Tucson, Arizona, United States
RECRUITINGKadima Neuropsychiatry Institute
San Diego, California, United States
RECRUITINGProvidence Medical Foundation
Santa Rosa, California, United States
RECRUITINGUniversity of Colorado
Aurora, Colorado, United States
RECRUITINGUniversity of South Florida, Department of Psychiatry and Behavioral Neuroscience
Tampa, Florida, United States
RECRUITINGEmory University
Atlanta, Georgia, United States
RECRUITINGHawaii Pacific Neuroscience
Honolulu, Hawaii, United States
RECRUITINGRush University Medical Center
Chicago, Illinois, United States
RECRUITINGLSU Health Shreveport
Shreveport, Louisiana, United States
RECRUITING...and 12 more locations